Li Xin Niu
Finanzdirektor/CFO bei AIM VACCINE CO., LTD.
Profil
Li Xin Niu is currently the Chief Financial Officer at AIM Vaccine Co., Ltd.
She previously worked as the Vice President-Finance at China Nuokang Bio-Pharmaceutical, Inc. from 2006 to 2012.
Before that, she was the Chief Financial Officer & Director at Beijing Dingcheng Weiye Technology Co., Ltd.
in 2003, Chief Financial Officer at Singapore City One Group Telecom Ltd.
(China) in 2005, and Vice President at Liaoning Zhongping Accounting Co., Ltd.
in 2006.
Ms. Niu received her undergraduate degree from Shenyang Industrial University in 1993 and her MBA from W.P.
Carey School of Business in 2020.
Aktive Positionen von Li Xin Niu
Unternehmen | Position | Beginn |
---|---|---|
AIM VACCINE CO., LTD. | Finanzdirektor/CFO | 01.10.2015 |
Ehemalige bekannte Positionen von Li Xin Niu
Unternehmen | Position | Ende |
---|---|---|
China Nuokang Bio-Pharmaceutical, Inc.
China Nuokang Bio-Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology China Nuokang Bio-Pharmaceutical, Inc. is a biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hematological and cardiovascular products. It currently sells a portfolio of fourteen products, including three principal products: Baquting, its flagship bleeding control product; Aiduo, its cardiovascular stress imaging agent; and Aiwen, its anti-arrhythmic agent. The company has also entered into an exclusive agreement for the marketing and distribution in China of Kaitong, an intravenous injectable lipid emulsion of vasodilator alprostadil for the treatment of peripheral vascular diseases, cardiocerebral microcirculation disorders and post-surgery thrombosis. Its product pipeline includes four product candidates under development that address the growing market and medical needs for hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. The company was founded on November 1997 and is headquartered in Shenyang, China. | Finanzdirektor/CFO | 15.12.2010 |
Liaoning Zhongping Accounting Co., Ltd. | Corporate Officer/Principal | 01.11.2006 |
Singapore City One Group Telecom Ltd. (China) | Finanzdirektor/CFO | 01.03.2005 |
Beijing Dingcheng Weiye Technology Co., Ltd. | Finanzdirektor/CFO | 01.12.2003 |
Ausbildung von Li Xin Niu
Shenyang Industrial University | Undergraduate Degree |
W.P. Carey School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
AIM VACCINE CO., LTD. | Health Technology |
Private Unternehmen | 4 |
---|---|
China Nuokang Bio-Pharmaceutical, Inc.
China Nuokang Bio-Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology China Nuokang Bio-Pharmaceutical, Inc. is a biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hematological and cardiovascular products. It currently sells a portfolio of fourteen products, including three principal products: Baquting, its flagship bleeding control product; Aiduo, its cardiovascular stress imaging agent; and Aiwen, its anti-arrhythmic agent. The company has also entered into an exclusive agreement for the marketing and distribution in China of Kaitong, an intravenous injectable lipid emulsion of vasodilator alprostadil for the treatment of peripheral vascular diseases, cardiocerebral microcirculation disorders and post-surgery thrombosis. Its product pipeline includes four product candidates under development that address the growing market and medical needs for hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. The company was founded on November 1997 and is headquartered in Shenyang, China. | Health Technology |
Beijing Dingcheng Weiye Technology Co., Ltd. | |
Singapore City One Group Telecom Ltd. (China) | |
Liaoning Zhongping Accounting Co., Ltd. |